IMF participants in the one-year clinical trial also stuck to their plans better, had lower drop-out rates and more often reached a 5% weight-loss benchmark the point at which vital health markers generally begin to improve
These authors concluded thatemaglutide/liraglutide offered kidney-protective effects, which appeared more pronounced in patients with preexisting CKD among individuals with T2D
Biomolecules 15(1):46 Lin L et al (2022) Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial
Much has been written about the cost of GLP-1s and the potential healthcare spend increase for employers and health plans if widespread coverage and utilization were to be adopted
However, finding the optimal dose for each patient requires close work with a healthcare provider
Khare S, Osumili B, Debackere N, et al